Technical Analysis for VAL - Valirx Plc

Grade Last Price % Change Price Change
F 20.75 0.00% 0.00
VAL closed unchanged on Monday, April 12, 2021, on 41 percent of normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Flat Down Flat
Historical VAL trend table...

Date Alert Name Type % Chg
200 DMA Resistance Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Doji - Bullish? Reversal 0.00%
Fell Below 200 DMA Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze Started Range Contraction 0.00%
200 DMA Support Bullish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.35%
Narrow Range Bar Range Contraction -2.35%
NR7 Range Contraction -2.35%
Older End-of-Day Signals for VAL ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Valirx Plc Description

ValiRx plc is a biopharmaceutical company. The principal activity of the Company is the development of oncology therapeutics and companion diagnostics. It focuses on the treatment of cancer and associated biomarkers, specializing in epigenomic and genetic analysis. It operates in two business segments: drug development and the sale of self-test drug kits. Its product pipeline includes VAL101, VAL201, VAL401 and Nav3. VAL201 is an anti-cancer therapeutic drug, which is in clinical trials for the treatment of prostate cancer and other indications of hormone induced unregulated growth including endometriosis. VAL401 is the reformulation of a generic drug for treatment of a chronic non-oncology disease in an oral capsule. VAL101 is a therapeutic based on its Gene Inactivation by chromatin engineering (GeneICE) platform. NAV3 Cancer Screening Test enables the detection of cancer cells in tissue samples. It operates through divisional companies, including ValiPharma, ValiFinn and ValiSeek.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Engineering Pharmaceutical Biotechnology Medicine Clinic Pipe Analysis Disease Life Sciences Cancer Oncology Clinical Trial Biopharmaceutical Biomarker Drug Development Biomarkers Cancer Screening Chemical Pathology Companion Diagnostic Prostate Cancer Treatment Of Cancer

Is VAL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 73.0
52 Week Low 3.3
Average Volume 706,038
200-Day Moving Average 20.84
50-Day Moving Average 22.05
20-Day Moving Average 21.64
10-Day Moving Average 20.75
Average True Range 1.42
ADX 13.22
+DI 19.10
-DI 17.86
Chandelier Exit (Long, 3 ATRs ) 22.05
Chandelier Exit (Short, 3 ATRs ) 23.30
Upper Bollinger Band 23.90
Lower Bollinger Band 19.38
Percent B (%b) 0.3
BandWidth 20.90
MACD Line -0.35
MACD Signal Line -0.34
MACD Histogram -0.0123
Fundamentals Value
Market Cap 13.46 Million
Num Shares 64.9 Million
EPS -0.50
Price-to-Earnings (P/E) Ratio -41.50
Price-to-Sales 0.00
Price-to-Book 5.78
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 22.10
Resistance 3 (R3) 22.03 21.52 21.88
Resistance 2 (R2) 21.52 21.17 21.55 21.80
Resistance 1 (R1) 21.13 20.96 21.20 21.20 21.72
Pivot Point 20.62 20.62 20.65 20.65 20.62
Support 1 (S1) 20.23 20.27 20.30 20.30 19.78
Support 2 (S2) 19.72 20.06 19.75 19.70
Support 3 (S3) 19.33 19.72 19.63
Support 4 (S4) 19.40